Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art


app icon


app store icon


Orthopedic and Dental Industry News Complete Archive »

Smith & Nephew Completes Acquisition of Surgical Robotics Business Blue Belt Technologies BY EDITOR, JANUARY 5, 2016

Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, announced it has completed the acquisition of Blue Belt Holdings, Inc. (“Blue Belt Technologies”), securing a leading position in the fast-growing area of orthopaedic robotics-assisted surgery.

Blue Belt Technologies’ Navio surgical system currently provides robotics-assistance in unicondylar or partial knee replacement surgery through CT-free navigation software and a unique hand-held, robotic bone-shaping device. Navio and Smith & Nephew’s partial knee implant portfolio form a strong combined business from which to accelerate growth in this attractive area of surgery. Additionally, the Group intends to expand the Navio platform into total knee, bi-cruciate retaining knee and revision knee implants, delivering significant further upside.


Ingeborg Øie
Smith & Nephew
+44 (0) 20 7960 2285

Financial Media
Charles Reynolds
Smith & Nephew
+44 (0) 20 7401 7646

Ben Atwell / Matthew Cole
FTI Strategic Consulting
+44 (0) 20 3727 1000

Trade Media
Joe Metzger
Smith & Nephew
+1 (978) 749-1330

About Smith & Nephew
Smith & Nephew is a global medical technology business dedicated to helping healthcare professionals improve people's lives. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma & Extremities, Smith & Nephew has around 14,000 employees and a presence in more than 100 countries. Annual sales in 2014 were more than $4.6 billion. Smith & Nephew is a member of the FTSE100 (LSE:SN, NYSE:SNN).

Email this to a colleague: